Forian Inc. (NASDAQ:FORA) released results for the quarter ended June 30, 2022.
Q2 2022 Financial Highlights
-
Net loss for the quarter was $5.4 million, or $0.17 per share, compared to $7.0 million, or $0.22 per share, in the prior year.
-
Adjusted EBITDA for the quarter was negative $3.2 million, compared to negative $3.6 million in the prior year.
-
Cash and marketable securities at the end of the quarter was $23.9 million.
Second Quarter 2022 Operational Highlights
-
Expanded capabilities of Chronos, the company's healthcare information product line
-
Completed integration of cannabis retail transactional data within the Forian data factory
"Forian delivered strong financial results in the second quarter, reflecting growing demand across our offerings," stated Max Wygod, Forian executive chairman. "The second quarter passed an inflection point in the business where we now see our growth directly driving towards substantial profitability."
Forian CEO Dan Barton stated, "Second quarter 2022 financial results built upon our momentum of strong sales of our subscription-based healthcare information offerings coupled with execution on cost management strategies."
Photo by Mackenzie Marco on Unsplash
Related News
ScottsMiracle-Gro, TerrAscend, Canopy Growth & Other Large Cannabis Stocks Announce Earnings Release Dates
BellRock Brands CFO Resigns, Interim CFO Appointed, Cannabis Company Still Under Cease Trade Order
EXCLUSIVE VIDEO: A Cannabis Culinary Paradise Valued At More Than $500M And The Secret Sauce Behind It
フォリアン社(ナスダック:FORA)は、2022年6月30日現在の四半期業績を発表した。
2022年第2四半期の財務ハイライト
2022年第2四半期の運営ポイント
フォリアンは第2四半期に強力な財務業績を発表し、私たちのすべての製品の需要が増加していることを反映しているマックス·ワイ神徳フリリアン執行議長“第2四半期は事業の転換点を経験し、私たちの成長が私たちの大幅な利益を直接推進していることを見ています”
フォリアン最高経営責任者ダン·バートン2022年第2四半期の財務業績は、購読している医療情報製品に基づく強力な販売勢いおよびコスト管理戦略の実行に構築されています
Mackenzie MarcoのUnspashでの写真
関連ニュース
ScotsMiracle-Gro、TerrAscend、Cancopy Growth、その他の大型大麻株の決算発表日
BellRock Brands CFOは辞任し、臨時CFOは任命され、大麻会社はまだ貿易停止令の下にあります
独占ビデオ:5億ドル以上の大麻調理天国とその背後の秘密のソース